The disclosure is directed to cocrystals of fasoracetam, including R-fasoracetam, and various coformers. Crystalline materials comprising fasoracetam, including R-fasoracetam, are also provided. The disclosure further includes pharmaceutical compositions and methods of treatment of the cocrystals and crystalline materials of the disclosure
Leyssens, T., Couch, R. A., Guillot, M., Harmsen, B., Bailey, T., & Appelmans, M. (2019). SOLID FORMS OF FASORACETAM. https://hdl.handle.net/2078.5/25802